Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer

Journal of Clinical Oncology

Volumn 31, Issue 18, 2013, Pages 2249-2256

  Li, Jingmei ^a   Humphreys, Keith ^b   Eriksson, Louise ^b   Edgren, Gustaf ^b,c   Czene, Kamila ^b   Hall, Per ^b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DENSITY; CANCER MORTALITY; CANCER PROGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CONGENITAL MALFORMATION; DRUG EFFECT; MAMMARY GLAND; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS; SURVIVAL;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTMENOPAUSE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 84882931934     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.5015     Document Type: Article

References (30)

1. Boyd NF, Rommens JM, Vogt K, et al: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808, 2005
2. Greendale GA, Reboussin BA, Slone S, et al: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30-37, 2003
3. McTiernan A, Martin CF, Peck JD, et al: Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women’s Health Initiative randomized trial. J Natl Cancer Inst 97:1366-1376, 2005
4. Cuzick J, Warwick J, Pinney E, et al: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621-628, 2004
5. Cuzick J, Warwick J, Pinney E, et al: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: A nested case-control study. J Natl Cancer Inst 103:744-752, 2011
6. Ursin G, Pike MC, Spicer DV, et al: Can mammographic densities predict effects of tamoxifen on the breast? J Natl Cancer Inst 88:128-129, 1996
7. Konez O, Goyal M, Reaven RE: Can tamoxifen cause a significant mammographic density change in breast parenchyma? Clin Imaging 25:303-308, 2001
8. Brisson J, Brisson B, Coté G, et al: Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9:911-915, 2000
9. Chow CK, Venzon D, Jones EC, et al: Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917-921, 2000
10. Magnusson C, Baron J, Persson I, et al: Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 76:29-34, 1998
11. Magnusson C, Baron JA, Correia N, et al: Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81:339-344, 1999
12. Magnusson CM, Persson IR, Baron JA, et al: The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Int J Cancer 80:231-236, 1999
13. Rosenberg LU, Granath F, Dickman PW, et al: Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: A cohort study. Breast Cancer Res 10:R78, 2008
14. Rosenberg LU, Einarsdóttir K, Friman EI, et al: Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:2482-2488, 2006
15. Nyström L, Larsson LG, Rutqvist LE, et al: Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials: A comparison between official statistics and validation by an endpoint committee. Acta Oncol 34:145-152, 1995
16. Tamimi RM, Eriksson L, Lagiou P, et al: Birth weight and mammographic density among postmenopausal women in Sweden. Int J Cancer 126: 985-991, 2010
17. Li J, Szekely L, Eriksson L, et al: High-throughput mammographic density measurement: A tool for risk prediction of breast cancer. Breast Cancer Res 14:R114, 2012
18. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al: The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24:659-667, 2009
19. Byng JW, Boyd NF, Fishell E, et al: The quantitative analysis of mammographic densities. Phys Med Biol 39:1629-1638, 1994
20. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2011
21. Fox J, Carvalho MS: The RcmdrPlugin.survival package: Extending the R commander interface to survival analysis (R package version 1.0-1). J Stat Software 49:1-32, 2012
22. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609-1618, 1998
23. Colzani E, Liljegren A, Johansson AL, et al: Prognosis of patients with breast cancer: Causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 29:4014-4021, 2011
24. American Cancer Society: Cancer Facts & Figures for African Americans 2011-2012. Atlanta, GA, American Cancer Society, 2011
25. Owusu C, Buist DS, Field TS, et al: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 26:549-555, 2008
26. Schroth W, Goetz MP, Hamann U, et al: Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 302:1429-1436, 2009
27. Maskarinec G, Nagata C, Shimizu H, et al: Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 102:29-33, 2002
28. Haars G, van Noord PA, van Gils CH, et al: Measurements of breast density: No ratio for a ratio. Cancer Epidemiol Biomarkers Prev 14:2634-2640, 2005
29. Son HJ, Oh KK: Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery. AJR Am J Roentgenol 173:905-909, 1999
30. Ursin G, Ma H, Wu AH, et al: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332-338, 2003